Inmagene Biopharmaceuticals ("Inmagene") announces that the U.S. Food and Drug Administration (FDA) has cleared drug candidate IMG-007, a monoclonal antibody against OX40, to proceed...
South India's diversified Sona Group has forged a 50:50 joint venture with Australia's Mycelium Biotechnology Group to set up a state-of-the art Mycelium research...
Intravacc B.V., a world leader in translational research and development of preventive and therapeutic vaccines, today announced the signing of an exclusive licensing agreement...
Huhtamaki, a key global provider of sustainable packaging solutions, announces a first-to-market sustainable innovation for the global pharmaceutical and healthcare industry. Huhtamaki's Push Tab...
The U.S. Food and Drug Administration(FDA ) issued draft action levels for lead in single-strength (ready to drink) apple juice and other single-strength juices...
